Guggenheim Capital LLC Has $2.67 Million Stake in Cardinal Health, Inc. $CAH

Guggenheim Capital LLC raised its holdings in Cardinal Health, Inc. (NYSE:CAH) by 43.6% during the 2nd quarter, according to its most recent filing with the Securities and Exchange Commission. The fund owned 15,915 shares of the company’s stock after buying an additional 4,833 shares during the period. Guggenheim Capital LLC’s holdings in Cardinal Health were worth $2,674,000 at the end of the most recent reporting period.

Several other institutional investors and hedge funds have also recently added to or reduced their stakes in the business. EverSource Wealth Advisors LLC boosted its stake in shares of Cardinal Health by 7.7% during the 2nd quarter. EverSource Wealth Advisors LLC now owns 2,348 shares of the company’s stock worth $394,000 after buying an additional 168 shares during the last quarter. Invesco Ltd. boosted its position in Cardinal Health by 7.3% during the second quarter. Invesco Ltd. now owns 3,037,782 shares of the company’s stock valued at $510,347,000 after purchasing an additional 207,750 shares during the last quarter. CW Advisors LLC grew its stake in Cardinal Health by 130.6% in the second quarter. CW Advisors LLC now owns 18,656 shares of the company’s stock valued at $3,134,000 after purchasing an additional 10,565 shares in the last quarter. PharVision Advisers LLC bought a new position in Cardinal Health in the second quarter valued at approximately $285,000. Finally, Twin Peaks Wealth Advisors LLC acquired a new position in shares of Cardinal Health during the 2nd quarter worth approximately $47,000. 87.17% of the stock is owned by institutional investors.

Cardinal Health Trading Down 0.2%

NYSE CAH opened at $198.48 on Tuesday. The company has a market cap of $47.16 billion, a price-to-earnings ratio of 29.94, a PEG ratio of 1.45 and a beta of 0.63. The company has a 50 day moving average of $183.47 and a 200-day moving average of $165.54. Cardinal Health, Inc. has a 1-year low of $114.60 and a 1-year high of $214.93.

Cardinal Health (NYSE:CAH) last posted its quarterly earnings data on Thursday, October 30th. The company reported $2.55 EPS for the quarter, topping analysts’ consensus estimates of $2.22 by $0.33. The firm had revenue of $64.01 billion for the quarter, compared to analyst estimates of $59.41 billion. Cardinal Health had a negative return on equity of 84.37% and a net margin of 0.68%.The company’s revenue was up 22.4% on a year-over-year basis. During the same quarter last year, the company earned $1.88 EPS. Cardinal Health has set its FY 2026 guidance at 9.650-9.850 EPS. On average, equities research analysts forecast that Cardinal Health, Inc. will post 7.95 earnings per share for the current year.

Cardinal Health Announces Dividend

The company also recently disclosed a quarterly dividend, which will be paid on Thursday, January 15th. Investors of record on Friday, January 2nd will be given a dividend of $0.5107 per share. The ex-dividend date of this dividend is Friday, January 2nd. This represents a $2.04 annualized dividend and a yield of 1.0%. Cardinal Health’s dividend payout ratio is currently 30.77%.

Analyst Ratings Changes

Several research firms have issued reports on CAH. Argus upped their price target on shares of Cardinal Health from $189.00 to $211.00 and gave the stock a “buy” rating in a research report on Tuesday, November 4th. Mizuho lifted their target price on shares of Cardinal Health from $170.00 to $210.00 and gave the stock an “outperform” rating in a report on Monday, November 3rd. Jefferies Financial Group set a $220.00 price target on shares of Cardinal Health and gave the company a “buy” rating in a research note on Monday, November 3rd. Weiss Ratings restated a “buy (b)” rating on shares of Cardinal Health in a research report on Wednesday, October 8th. Finally, Evercore ISI upped their target price on Cardinal Health from $190.00 to $220.00 and gave the company an “outperform” rating in a research report on Friday, October 31st. Thirteen research analysts have rated the stock with a Buy rating and three have issued a Hold rating to the company’s stock. According to MarketBeat.com, the stock presently has an average rating of “Moderate Buy” and a consensus price target of $209.00.

Cardinal Health Company Profile

Cardinal Health, Inc operates as a healthcare services and products company in the United States, Canada, Europe, Asia, and internationally. It provides customized solutions for hospitals, healthcare systems, pharmacies, ambulatory surgery centers, clinical laboratories, physician offices, and patients in the home.